
Haloteco Announces Voluntary Nationwide Recall of Libipower Plus
Earlier this week, manufacturer Haloteco (Los Angeles) announced a voluntary nationwide recall of its product Libipower Plus, according to FDA (Rockville, MD). The recall came when FDA reported finding tadalalafil in lab analysis of product samples.
Earlier this week, manufacturer Haloteco (Los Angeles) announced a voluntary nationwide recall of its product Libipower Plus, according to FDA (Rockville, MD). The recall came when FDA reported finding tadalalafil in lab analysis of product samples.
Tadalalafil is the active ingredient in FDA-approved drugs prescribed for erectile dysfunction that may cause various dangerous side effects like low blood pressure and interaction with nitrates found in certain prescription drugs.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





